HealthDay News — Patients with psychiatric disorders have an increased rate of sudden cardiac death (SCD), according to a study published online Oct. 22 in Heart.

HealthDay News — Urban green spaces appear to play an important role in mitigating heat-related health risks, according to a review published online Oct. 22 in BMJ Open.

Long-term exposure to inorganic arsenic in drinking water (wAs) from U.S. community water supplies (CWS) at levels below the federal maximum contaminant level of 10 µg/L is associated with an ...

Treatment with bimekizumab yields significant and rapid improvements in patient-reported symptoms and enhanced HRQOL among individuals with PsA.

In a systematic review, the incidence of gastrointestinal-related adverse events associated with the use of biologic therapies for psoriasis was 8.7%.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

For patients with axial spondyloarthritis (axSpA) who experience extra musculoskeletal symptoms such as acute anterior uveitis, bimekizumab (BKZ) may offer protective benefits, according to study ...

Secukinumab is safe and effective over a 48-month period among patients with PsA, demonstrating sustained disease control and high drug retention rates.

Infant mortality was higher than expected, both overall and among those with congenital anomalies, for several months after the U.S. Supreme Court decision in Dobbs v Jackson Women’s Health ...

Rates of long-term treatment discontinuation were low among patients with ankylosing spondylitis receiving first-line anti-TNF therapy for at least 2 years.

A healthy sleep pattern and a moderate level of physical activity is associated with a decreased risk of developing rheumatoid arthritis.

HealthDay News — For patients with ulcerative colitis, the HLA-DRB1*01:03 allele is associated with severe ulcerative colitis, according to a research letter published online Oct. 15 in the Journal of ...